Date Filed | Type | Description |
08/10/2023 |
4
| Moriarty John B (Chief Legal Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/19/2020 |
4
| Moriarty John B (EVP, Ch. Legal Officer & Sec.) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns:
| Granted 252,060 options to buy
@ $4.824, valued at
$1.2M
Granted 161,406 options to buy
@ $19, valued at
$3.1M
|
|
11/18/2020 |
3
| Moriarty John B (EVP, Ch. Legal Officer & Sec.) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2020 |
4
| Moriarty John B (EVP, General Counsel) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Granted 16,250 shares
@ $0 Paid exercise price by delivering 3,544 shares
@ $12.89, valued at
$45.7k
Granted 65,000 options to buy
@ $12.79, valued at
$831.4k
|
|
03/05/2019 |
4
| Moriarty John B (EVP, General Counsel) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 4,297 shares
@ $33.42, valued at
$143.6k
|
|
02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/30/2018 |
4
| Moriarty John B (EVP, General Counsel) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Granted 25,000 shares
@ $0 Granted 125,000 options to buy
@ $32.66, valued at
$4.1M
|
|
03/20/2018 |
3
| Moriarty John B (EVP, General Counsel) has filed a Form 3 on PORTOLA PHARMACEUTICALS INC |
02/08/2018 |
4
| Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 2,163 shares
@ $115.7, valued at
$250.3k
Sold 1,200 shares
@ $115.7, valued at
$138.8k
Granted 21,489 shares
@ $0 Granted 6,500 shares
@ $0 |
|
02/07/2018 |
4
| Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 1,261 shares
@ $117.26, valued at
$147.9k
|
|
03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/13/2016 |
4
| Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 1,044 shares
@ $118.61, valued at
$123.8k
|
|
08/10/2016 |
4
| Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 135 shares
@ $137.14, valued at
$18.5k
|
|
06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/01/2016 |
4
| Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 5,000 shares
@ $0 Sold 1,200 shares
@ $138.91, valued at
$166.7k
Sold 1 shares
@ $140.65, valued at
$140.7 Granted 31,000 options to buy
@ $140.16, valued at
$4.3M
|
|
02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/08/2013 |
4
| Moriarty John B (SVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 2,200 shares
@ $0 Granted 29,600 options to buy
@ $93.83, valued at
$2.8M
|
|
12/18/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |